ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
3.025
+0.055 (1.85%)
Aug 14, 2025, 1:41 PM - Market open
ABVC BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -4.33 | -4.9 | -7.79 | -16.42 | -12.84 | -9.79 | Upgrade
|
| Depreciation & Amortization | 0.28 | 0.2 | 0.38 | 0.02 | 0.01 | 0.04 | Upgrade
|
| Other Amortization | - | - | - | 0.11 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | 1 | Upgrade
|
| Loss (Gain) on Equity Investments | 0.36 | 0.34 | 0.22 | - | 0.27 | 1.17 | Upgrade
|
| Stock-Based Compensation | 1.95 | 2.77 | 0.19 | 7.04 | 5.31 | 4.15 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.01 | 0.01 | 1.46 | 0.18 | - | - | Upgrade
|
| Other Operating Activities | 0.43 | 0.18 | 0.87 | 1.03 | 1.27 | -1.04 | Upgrade
|
| Change in Accounts Receivable | - | - | 0.23 | -0.61 | -0.12 | 0 | Upgrade
|
| Change in Inventory | -0.01 | - | - | - | -0.03 | - | Upgrade
|
| Change in Accounts Payable | - | - | - | - | -0.02 | -0 | Upgrade
|
| Change in Unearned Revenue | 0 | 0 | 0.07 | - | - | - | Upgrade
|
| Change in Income Taxes | 0.02 | -0.11 | 0.11 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 0.02 | -0.3 | 0.08 | 1.25 | -1.44 | -0.09 | Upgrade
|
| Operating Cash Flow | -1.27 | -1.81 | -4.19 | -7.4 | -7.6 | -4.56 | Upgrade
|
| Capital Expenditures | - | - | -0.02 | -0.12 | -0.02 | - | Upgrade
|
| Investment in Securities | - | - | -0.34 | -1.6 | -0.79 | 0.15 | Upgrade
|
| Other Investing Activities | -0.67 | - | - | - | - | -0.37 | Upgrade
|
| Investing Cash Flow | -0.67 | - | -0.36 | -1.72 | -0.81 | -0.23 | Upgrade
|
| Short-Term Debt Issued | - | 0.03 | - | 0.35 | 0 | 0.17 | Upgrade
|
| Long-Term Debt Issued | - | 0.94 | 1.46 | - | 0.24 | 2.62 | Upgrade
|
| Total Debt Issued | 0.67 | 0.97 | 1.46 | 0.35 | 0.24 | 2.8 | Upgrade
|
| Short-Term Debt Repaid | - | -0.03 | -1 | - | -0.1 | -0.83 | Upgrade
|
| Long-Term Debt Repaid | - | -0.33 | -0.19 | - | -0.41 | -0.01 | Upgrade
|
| Total Debt Repaid | -0.46 | -0.36 | -1.19 | - | -0.51 | -0.84 | Upgrade
|
| Net Debt Issued (Repaid) | 0.21 | 0.62 | 0.28 | 0.35 | -0.27 | 1.95 | Upgrade
|
| Issuance of Common Stock | 2.56 | 0.98 | 1.05 | 3.66 | 11.12 | 7.62 | Upgrade
|
| Repurchase of Common Stock | -0.01 | -0.01 | - | - | - | - | Upgrade
|
| Other Financing Activities | -0.22 | 0.39 | 2.54 | - | -0.85 | - | Upgrade
|
| Financing Cash Flow | 2.54 | 1.98 | 3.87 | 4.01 | 10 | 9.57 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.27 | -0.02 | 0 | -0.07 | -0.03 | 0.06 | Upgrade
|
| Net Cash Flow | 0.33 | 0.15 | -0.67 | -5.17 | 1.56 | 4.84 | Upgrade
|
| Free Cash Flow | -1.27 | -1.81 | -4.21 | -7.52 | -7.62 | -4.56 | Upgrade
|
| Free Cash Flow Margin | -325.44% | -355.02% | -2760.64% | -775.23% | -2140.33% | -944.82% | Upgrade
|
| Free Cash Flow Per Share | -0.09 | -0.15 | -0.97 | -2.37 | -3.04 | -2.31 | Upgrade
|
| Cash Interest Paid | 0.02 | 0.02 | 0.03 | 0.29 | 0.33 | 0.21 | Upgrade
|
| Cash Income Tax Paid | 0 | 0.03 | 0.03 | 0 | - | - | Upgrade
|
| Levered Free Cash Flow | 0.1 | -0.98 | -2.37 | -2.25 | -2.66 | -2.5 | Upgrade
|
| Unlevered Free Cash Flow | 0.56 | -0.46 | -1.55 | -2.06 | -2.52 | -2.25 | Upgrade
|
| Change in Working Capital | 0.04 | -0.41 | 0.49 | 0.64 | -1.61 | -0.09 | Upgrade
|
Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.